Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model

被引:4
|
作者
Zhang, Xueying [1 ]
He, Zijun [1 ]
Zhang, Yucong [2 ]
Kong, Jian [3 ]
机构
[1] Jinan Univ, Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
[2] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Clin Med Coll 2, Dept Radiat Oncol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[3] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Affiliated Hosp 1, Dept Intervent Radiol,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
关键词
hepatocellular carcinoma; drug-eluting beads transcatheter arterial chemoembolization; initial response; objective response; computed tomography; radiomics; nomogram; prediction; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-CANCER; TIME-POINT; DC BEAD; MRECIST; CLASSIFICATION; SURVIVAL; HETEROGENEITY; SYSTEM; EASL;
D O I
10.3389/fphar.2024.1315732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: A prognostic model utilizing CT radiomics, radiological, and clinical features was developed and validated in this study to predict an objective response to initial transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma (HCC).Methods: Between January 2017 and December 2022, the baseline clinical characteristics and preoperative and postoperative follow-up imaging data of 108 HCC patients who underwent the first time treatment of DEB-TACE were analyzed retrospectively. The training group (n = 86) and the validation group (n = 22) were randomly assigned in an 8:2 ratio. By logistic regression in machine learning, radiomics, and clinical-radiological models were constructed separately. Finally, the integrated model construction involved the integration of both radiomics and clinical-radiological signatures. The study compared the integrated model with radiomics and clinical-radiological models using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA).Results: The objective response rate observed in a group of 108 HCC patients who received initial DEB-TACE treatment was found to be 51.9%. Among the three models, the integrated model exhibited superior predictive accuracy in both the training and validation groups. The training group resulted in an area under the curve (AUC) of 0.860, along with sensitivity and specificity values of 0.650 and 0.913, respectively. Based on the findings from the validation group, the AUC was estimated to be 0.927. Additionally, it was found that values of sensitivity and specificity were 0.875 and 0.833, respectively. In the validation group, the AUC of the integrated model showed a significant improvement when contrasted to the clinical-radiological model (p = 0.042). Nevertheless, no significant distinction was observed in the AUC when comparing the integrated model with the radiomics model (p = 0.734). The DCA suggested that the integrated model demonstrates advantageous clinical utility.Conclusion: The integrated model, which combines the CT radiomics signature and the clinical-radiological signature, exhibited higher predictive efficacy than either the radiomics or clinical-radiological models alone. This suggests that during the prediction of the objective responsiveness of HCC patients to the first DEB-TACE treatment, the integrated model yields superior outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] The update on transcatheter arterial chemoembolization using drug-eluting beads: Optimization for best response
    Oh, Jung Suk
    Chun, Ho Jong
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2021, 10 (04): : 161 - 164
  • [2] Apparent Diffusion Coefficient as a Noninvasive Biomarker for the Early Response in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Using Drug-eluting Beads
    Li, Basen
    Zhou, Lei
    Xu, Anhui
    Li, Qin
    Xiang, Huihua
    Huang, Yanrong
    Peng, Ling
    Xiang, Kun
    Zhang, Mingfeng
    Wang, Nan
    CURRENT MEDICAL IMAGING, 2022, 18 (11) : 1186 - 1194
  • [3] Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma
    Iezzi, Roberto
    Pompili, Maurizio
    La Torre, Michele Fabio
    Campanale, Maria Chiara
    Montagna, Martina
    Saviano, Antonio
    Cesario, Valentina
    Siciliano, Massimo
    Annicchiarico, Eleonora
    Agnes, Salvatore
    Giuliante, Felice
    Grieco, Antonio
    Rapaccini, Gian Lodovico
    De Gaetano, Anna Maria
    Gasbarrini, Antonio
    Bonomo, Lorenzo
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (03) : 242 - 248
  • [4] Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
    Murata, Yosuke
    Hiramatsu, Katsushi
    Yoshida, Yumi
    Akazawa, Yu
    Saito, Yasushi
    Nosaka, Takuto
    Ozaki, Yoshihiko
    Hayama, Ryoko
    Takahashi, Kazuto
    Naito, Tatsushi
    Ofuji, Kazuya
    Matsuda, Hidetaka
    Ohtani, Masahiro
    Nemoto, Tomoyuki
    Nakamoto, Yasunari
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2019, 12 (01) : 76 - 81
  • [5] Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
    Yosuke Murata
    Katsushi Hiramatsu
    Yumi Yoshida
    Yu Akazawa
    Yasushi Saito
    Takuto Nosaka
    Yoshihiko Ozaki
    Ryoko Hayama
    Kazuto Takahashi
    Tatsushi Naito
    Kazuya Ofuji
    Hidetaka Matsuda
    Masahiro Ohtani
    Tomoyuki Nemoto
    Yasunari Nakamoto
    Clinical Journal of Gastroenterology, 2019, 12 : 76 - 81
  • [6] Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion
    Nishi, Maiko
    Saeki, Issei
    Yamasaki, Takahiro
    Maeda, Masaki
    Hisanaga, Takuro
    Iwamoto, Takuya
    Matsumoto, Toshihiko
    Hidaka, Isao
    Ishikawa, Tsuyoshi
    Takami, Taro
    Sakaida, Isao
    HEPATOLOGY RESEARCH, 2018, 48 (04) : 329 - 332
  • [7] The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
    Han, Tao
    Yang, Xiaodan
    Zhang, Yue
    Li, Gao
    Liu, Lu
    Chen, Tingsong
    Zheng, Zhendong
    BIOSCIENCE TRENDS, 2019, 13 (05) : 374 - 381
  • [8] A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization
    Morshid, Ali
    Elsayes, Khaled M.
    Khalaf, Ahmed M.
    Elmohr, Mohab M.
    Yu, Justin
    Kaseb, Ahmed O.
    Hassan, Manal
    Mahvash, Armeen
    Wang, Zhihui
    Hazle, John D.
    Fuentes, David
    RADIOLOGY-ARTIFICIAL INTELLIGENCE, 2019, 1 (05)
  • [9] Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
    Liu, Kai-Cai
    Lv, Wei-Fu
    Lu, Dong
    Hou, Chang-Long
    Xie, Jun
    Lu, Yu-He
    Cao, Qi-Sheng
    Tan, Yu-Lin
    Zhang, Ying-Zhan
    Liu, Jie
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7973 - 7980
  • [10] Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
    Kobayashi, Saito
    Tajiri, Kazuto
    Murayama, Aiko
    Entani, Toshiki
    Futsukaichi, Yuka
    Nagata, Kohei
    Takahashi, Kosuke
    Yasuda, Ichiro
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2020, 7 : 181 - 189